PRESS RELEASE published on 03/25/2026 at 15:11, 6 months 28 days ago NANOBIOTIX Statement Regarding Recent Media Speculation Nanobiotix issues statement addressing media speculation on public take-over intentions, denying any such plans and highlighting factual inaccuracies in recent reports Media Speculation Statement NANOBIOTIX Public Take-over Factual Inaccuracies
BRIEF published on 03/12/2026 at 21:20, 7 months 10 days ago Nanobiotix Announces Voting Rights and Share Capital Details Euronext Paris Share Capital Voting Rights Nasdaq NANOBIOTIX
BRIEF published on 03/12/2026 at 21:20, 7 months 10 days ago Nanobiotix annonce les détails relatifs aux droits de vote et au capital social Euronext Paris Capital Social Nasdaq Droit De Vote NANOBIOTIX
PRESS RELEASE published on 03/12/2026 at 21:15, 7 months 10 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital details as of February 28, 2026, on Euronext Paris and Nasdaq markets. Learn about their disruptive therapeutic approaches and global presence Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/25/2026 at 22:20, 7 months 25 days ago NANOBIOTIX Presents at Key Conferences in March Biotechnology Investor Conferences Cancer Treatments NANOBIOTIX Clinical Advances
BRIEF published on 02/25/2026 at 22:20, 7 months 25 days ago NANOBIOTIX Présente à des Conférences Clés en Mars Biotechnologie Conférences Investisseurs NANOBIOTIX Avancées Cliniques Traitements Cancer
PRESS RELEASE published on 02/25/2026 at 22:15, 7 months 25 days ago NANOBIOTIX participera à plusieurs conférences investisseurs en mars Nanobiotix participera à plusieurs conférences investisseurs en mars. Détails sur les événements et les participants. La société présentera ses approches novatrices en biotechnologie Biotechnologie Cancer Conférences Investisseurs NANOBIOTIX Approches Therapeutiques
BRIEF published on 02/17/2026 at 22:20, 8 months 5 days ago Nanobiotix annonce une mise à jour de ses droits de vote et de son capital social Euronext Paris Capital Social Droit De Vote Divulgation Financière NANOBIOTIX
BRIEF published on 02/17/2026 at 22:20, 8 months 5 days ago Nanobiotix Announces Updated Voting Rights and Share Capital Euronext Paris Voting Rights Shares Capital Financial Disclosure NANOBIOTIX
PRESS RELEASE published on 02/17/2026 at 22:15, 8 months 5 days ago Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Nanobiotix publie son information mensuelle sur les droits de vote et actions. La société développe des traitements innovants en biotechnologie Droits De Vote Biotechnologie Actions Traitements NANOBIOTIX
Published on 10/23/2026 at 02:20, 9 hours 1 minute ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 11 hours 51 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 12 hours 51 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 19 hours 21 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 20 hours 51 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 11:00, 20 minutes ago Annual General Meeting Approves Contribution: Innok Robotics on Course for the Public Capital Market
Published on 10/23/2026 at 10:18, 1 hour 2 minutes ago Schirp Schjmidt-Morsbach Rechtsanwälte PartG: Investor Lawsuits in the Wirecard Case: Federal Court of Justice Dismisses EY from Model Proceedings The lead plaintiff’s attorneys welcome the decision
Published on 10/23/2026 at 10:05, 1 hour 15 minutes ago SINEXCEL Achieves IEC 62443-4-1 Certification for Cybersecurity Compliance
Published on 10/23/2026 at 09:00, 2 hours 20 minutes ago Municipality Finance issues a USD 135 million tap under its MTN programme
Published on 10/23/2026 at 07:00, 4 hours 21 minutes ago Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 17 hours 21 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 17 hours 21 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 17 hours 21 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
